Yes ghia. Safety is paramount, but it also needs to have a positive impact on disease. Otherwise, it’s a pretty expensive drug that has little impact. Let’s wait for the spin from RM and team.
Manifesto Yes, that was an interesting read. Lots of positives coming out of the P2 but also, a few Profs asking for more detail and conclusive evidence. Lets hope that once the P3 results have been stripped back, some of those questions will be answered.
Agreed ray. You would have thought with our current Global climate that people should be a bit nicer, at least for a while. Never mind, I suppose it’s difficult when Governments can’t set the example.
Yes, God, ndn. I, for one, think of other’s feelings. If you’ve read their posts, you might understand. Then, again, you aren’t interested in others are you. Good day!
Boyg Look after yourself, don’t be too hard on yourself! We all invested for very valid reasons, we all thought it was nailed on which, in hindsight, was a mistake. Hopefully, the company can recover and so will you.
RM needs to use his communications officer, Brooke Clarke, to explain just what their thoughts are on the P3 trial outcomes. In my opinion, this needs to be done by close of play tomorrow. I don’t expect full analysis to be completed by then, although you could argue they have had enough time to do so. But, just a little something to let us know if we are still investing our money in the right place. This is in the job description of any CEO to assure shareholders that they are investing their money wisely and that they should feel confident in their investment for the following reasons. I await news with intrigue. GLA